
Ticagrelor monotherapy cuts bleeding risk in acute coronary syndrome
A study found that treatment with ticagrelor alone, rather than in combination with aspirin, led to a lower rate of clinically relevant bleeding in patients with acute coronary syndrome who underwent percutaneous coronary intervention. The study involved adults who remained event-free for one month on dual antiplatelet therapy after their procedure. Participants were randomly assigned…